Axogen, Inc. is 2.0x more valuable than CONMED Corp by market capitalization ($2.19 B vs $1.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CNMD | AXGN |
|---|---|---|
| Market cap | $1.11 B | $2.19 B |
| US-listed rank | #2567 | #2038 |
| Revenue (latest FY) | $1.37B | $225.21M |
| Net income (latest FY) | $47.10M | -$15.70M |
| Net margin | 3.4% | -7.0% |
| P/E (trailing FY) | 23.5 | - |
| SEC filings | 2,228 | 1,334 |
Axogen, Inc. is 2.0x more valuable than CONMED Corp by market capitalization ($2.19 B vs $1.11 B).
In their latest fiscal years, CONMED Corp reported $1.37B in revenue while Axogen, Inc. reported $225.21M.
Full pages: CONMED Corp and Axogen, Inc., or browse the full rankings.